# UNITED STATES ANTIMONY CORPORATION (UAMY) · Edgar & Edgarette company card > United States Antimony (UAMY) grew revenue 163% in FY2025 to $39 million, operating margin -21.5% against a 8.1% median for primary smelting & refining of nonferrous metals, equity 91.6% of assets. Every figure is from the company’s own annual report filed with the SEC. SEC CIK 101538 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/UAMY) · [JSON](https://www.pops4.com/boards/company/UAMY.json) ## Figures, as filed in the 10-K | Measure | Value | |---|---| | Revenue | $39M | | Revenue growth, 1 year | 162.8% | | Revenue growth per year | 50.0% | | Operating margin | -21.5% (prior year -16.0%) | | Net margin | -11.1% | | Operating cash flow | −$10M | | Capital spending | $28M | | Free cash flow | −$37M | | Cash | $30M | | Long-term debt | $195,425 | | Total assets | $154M | | Total equity | $141M | | Equity ÷ assets | 91.6% | | Return on equity | -3.1% | | Dividend per share | — | | Dividend years rising | — | ## Readings, computed from those figures - Altman Z: 11.98 (safe zone) - Piotroski F: 4 of 9 (middling) - Health Harbor boat: Rotting at the dock · four or more warning signs · filed auditor change in the last 12 months; operating cash flow was negative; operating loss: a margin of -21.5% in FY2025; revenue is hard to predict: its 80% range is ±71% - Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far ## Edgarette's reading Exposure: revenue $39.3M (FY2025), total debt $195K. Experience: revenue up 162.8% on the year, up 50.0% a year over 4 years; operating margin -21.5%, down from -16.0%. Soundness: equity 91.6% of assets, return on equity -3.1%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $33.2M and $194.6M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $29.5M to $220.6M. A statistical range, not company guidance. Against peers (17 filers, $50M+ revenue, its industry group): operating margin -21.5% against a 8.1% median; growth 162.8% against 10.6%. Range logged 2026-09-30, receipt 42e4e9b9951e99c1, status open. A statistical range, not company guidance. ## Health Watch, last 12 months - Item 3.01 Exchange listing notice or transfer: 1, latest 2026-03-06 ([filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926024423/0001104659-26-024423-index.htm)) - Item 4.01 Auditor change: 1, latest 2026-06-08 ([filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926071104/0001104659-26-071104-index.htm)) - Item 5.02 Director or officer change: 4, latest 2026-10-02 ([filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926113036/0001104659-26-113036-index.htm)) ## Recent filings - 8-K · filed 2026-10-26 · 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926118600/0001104659-26-118600-index.htm) - 8-K · filed 2026-10-02 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926113036/0001104659-26-113036-index.htm) - 8-K · filed 2026-10-02 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926113034/0001104659-26-113034-index.htm) - 8-K · filed 2026-08-25 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926100539/0001104659-26-100539-index.htm) - 8-K · filed 2026-08-19 · 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926098593/0001104659-26-098593-index.htm) - 8-K · filed 2026-08-17 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926097708/0001104659-26-097708-index.htm) ## Sources - facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000101538.json - filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=101538 ## Cite POPS4, Edgar & Edgarette: UNITED STATES ANTIMONY CORPORATION (UAMY) company card, from the company's own SEC filings, accessed 2026-11-03, https://www.pops4.com/boards/company/UAMY. CC BY 4.0. For a figure, add the filing URL under filings or sources. DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4. Reporting, not investment advice. No price targets and no trading recommendations. Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.